Pharmaceutical firms face escalating cyber threats fueled by cloud adoption, human error, and underfunded IT systems. With 98% of UK pharma organizations impacted by security events and ransomware disrupting critical operations, safeguarding intellectual property and patient data has become urgent. To stay resilient, the sector must modernize IT infrastructure, secure supply chains, and adopt advanced detection tools while meeting stricter compliance demands.
